CliffBio
small molecule

FENOPROFEN CALCIUM

FENOPROFEN CALCIUM

Loss of exclusivity—loss of exclusivity
CompanyPar →See this company's full patent-cliff portfolio

Drug detail

Brand nameFENOPROFEN CALCIUM
Active ingredientFENOPROFEN CALCIUM
StrengthEQ 200MG BASE
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalAugust 1988
Marketing statusDISCN

More from Par

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

FENOPROFEN CALCIUM patent cliff — loss of exclusivity — | CliffBio